scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company’s lead product candidate is FUROSCIX that consists of proprietary buffered formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. to incorporate SmartDose drug delivery system with Furoscix. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.
Search:
You do not have permission to access this chart.
Please Sign Up or Login
News for scPharmaceuticals Inc. (SCPH)
minutes ago | Banggood.com
58 minutes ago | Aliexpress.com
4 days ago | GlobeNewsWire
a month ago | Benzinga
a month ago | GlobeNewsWire
a month ago | Pulse2
2 months ago | GlobeNewsWire
3 months ago | GlobeNewsWire
5 months ago | Benzinga
5 months ago | GlobeNewsWire
6 months ago | GlobeNewsWire